Aethlon Medical (AEMD)

$1.90 -0.12 (-5.94%)
Market Cap 3.04M
Revenue (ttm) 0.00
Net Income (ttm) -13.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 340,500
Avg Vol 692,236
Day's Range N/A - N/A
Shares Out 1.57M
Stochastic %K 14%
Beta 1.49
Analysts Hold
Price Target $4.75

Company Profile

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Industry: Medical Devices
Sector: Healthcare
Phone: 619 941 0360
Fax: 619 941 0361
Address:
11555 Sorrento Valley Road, Suite 203, San Diego, United States
Alpha__Trading
Alpha__Trading Jun. 11 at 7:40 PM
$AEMD not many shares left to buy, PR soon
0 · Reply
ZacksSCR
ZacksSCR Jun. 11 at 7:19 PM
$AEMD Clinical Study Advances to Final Cohort; Preclinical Activities Expand https://buff.ly/20Br26y
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:40 PM
$84B+ biotech M&A in Q1 2026. big pharma buying pipelines at scale. DPX platform sitting at the intersection of oncology and infectious disease with peer reviewed data. halt lifts when filing drops. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:35 PM
DPX covering oncology AND infectious disease simultaneously. two Nature publications. DoD melanoma funding application. CEPI Ebola submission. one platform, multiple disease categories. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:31 PM
CEPI pre-proposal due tomorrow June 12. filing still pending. two catalysts that could completely change the story. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
UNCLE_SCROOGE_
UNCLE_SCROOGE_ Jun. 11 at 3:23 PM
$AEMD flush the scam...🤣🤣🤣
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 2:52 PM
$CODX $CMND $AEMD
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 11:03 AM
$CODX $AEMD $VRAX
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 10:53 AM
$VRAX $EBS $CODX $AEMD $GOVX https://share.google/pX9BFFpjPEjwnE4FM
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 3:01 AM
$AEMD $VRAX $CODX $EBS $PGEN https://share.google/cpZbwOapzh3mC7jtI
0 · Reply
Latest News on AEMD
Aethlon Medical Earnings Call Transcript: Q4 2026

Jun 10, 2026, 4:30 PM EDT - 1 day ago

Aethlon Medical Earnings Call Transcript: Q4 2026

Aethlon Medical Earnings release: Q4 2026

Jun 10, 2026, 4:30 PM EDT - 1 day ago

Aethlon Medical Earnings release: Q4 2026

Aethlon Medical Annual report: Q4 2026

Jun 10, 2026, 4:30 PM EDT - 1 day ago

Aethlon Medical Annual report: Q4 2026

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

Jun 10, 2026, 4:15 PM EDT - 1 day ago

Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Jun 2, 2026, 8:01 AM EDT - 9 days ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

May 21, 2026, 8:01 AM EDT - 21 days ago

Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness

Aethlon Medical Transcript: Emerging Growth Conference 91

Apr 2, 2026, 4:40 PM EDT - 2 months ago

Aethlon Medical Transcript: Emerging Growth Conference 91

Aethlon Medical Slides: Corporate presentation

Mar 27, 2026, 8:00 AM EDT - 2 months ago

Aethlon Medical Slides: Corporate presentation

Advancements in Novel Immunotherapeutics in The Oncology Battle

Mar 24, 2026, 10:30 AM EDT - 2 months ago

Advancements in Novel Immunotherapeutics in The Oncology Battle

Aethlon Medical advances to final cohort in AEMD-2022-06 trial

2026-03-24T12:11:30.000Z - 2 months ago

Aethlon Medical advances to final cohort in AEMD-2022-06 trial

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Mar 24, 2026, 8:01 AM EDT - 2 months ago

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Aethlon Medical Transcript: Life Sciences Virtual Investor Forum

Mar 12, 2026, 1:00 PM EDT - 3 months ago

Aethlon Medical Transcript: Life Sciences Virtual Investor Forum

Aethlon Medical to evaluate range of strategic opportunities

2026-03-12T12:06:49.000Z - 3 months ago

Aethlon Medical to evaluate range of strategic opportunities

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Mar 12, 2026, 8:01 AM EDT - 3 months ago

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th

Mar 6, 2026, 8:35 AM EST - 3 months ago

Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th

Aethlon Medical Transcript: Emerging Growth Virtual Conference

Feb 25, 2026, 12:35 PM EST - 3 months ago

Aethlon Medical Transcript: Emerging Growth Virtual Conference

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Feb 23, 2026, 8:01 AM EST - 3 months ago

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Aethlon Medical Earnings Call Transcript: Q3 2026

Feb 12, 2026, 4:30 PM EST - 4 months ago

Aethlon Medical Earnings Call Transcript: Q3 2026

Aethlon Medical Quarterly report: Q3 2026

Feb 12, 2026, 4:30 PM EST - 4 months ago

Aethlon Medical Quarterly report: Q3 2026

Aethlon Medical Earnings release: Q3 2026

Feb 12, 2026, 4:30 PM EST - 4 months ago

Aethlon Medical Earnings release: Q3 2026

Aethlon Medical reports Q3 EPS ($2.45) vs. ($10.05) last year

2026-02-12T21:22:12.000Z - 4 months ago

Aethlon Medical reports Q3 EPS ($2.45) vs. ($10.05) last year

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Feb 12, 2026, 4:15 PM EST - 4 months ago

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

Feb 4, 2026, 8:01 AM EST - 4 months ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

Aethlon Medical Proxy statement: Proxy Filing

Jan 27, 2026, 7:00 AM EST - 4 months ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical Proxy statement: Proxy Filing

Jan 16, 2026, 7:00 AM EST - 5 months ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical files to sell 2.03M shares of common stock for holders

2026-01-07T21:21:45.000Z - 5 months ago

Aethlon Medical files to sell 2.03M shares of common stock for holders

Aethlon Medical Registration statement: Registration Filing

Jan 7, 2026, 7:00 AM EST - 5 months ago

Aethlon Medical Registration statement: Registration Filing

Aethlon Medical files to sell $15M of common stock

2025-12-23T20:10:15.000Z - 6 months ago

Aethlon Medical files to sell $15M of common stock

Aethlon Medical Registration statement: Registration Filing

Dec 23, 2025, 7:00 AM EST - 6 months ago

Aethlon Medical Registration statement: Registration Filing

Aethlon Medical announces $3.3M private placement

2025-12-05T14:20:35.000Z - 6 months ago

Aethlon Medical announces $3.3M private placement

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Dec 5, 2025, 9:15 AM EST - 6 months ago

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Aethlon Medical’s Hemopurifier shows potential efficacy in long COVID

2025-12-02T13:10:50.000Z - 6 months ago

Aethlon Medical’s Hemopurifier shows potential efficacy in long COVID

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Dec 2, 2025, 8:01 AM EST - 6 months ago

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Aethlon Medical Earnings Call Transcript: Q2 2026

Nov 12, 2025, 4:30 PM EST - 7 months ago

Aethlon Medical Earnings Call Transcript: Q2 2026

Aethlon Medical Quarterly report: Q2 2026

Nov 12, 2025, 4:30 PM EST - 7 months ago

Aethlon Medical Quarterly report: Q2 2026

Aethlon Medical Earnings release: Q2 2026

Nov 12, 2025, 4:30 PM EST - 7 months ago

Aethlon Medical Earnings release: Q2 2026

Aethlon Medical reports Q2 EPS ($3.74) vs. ($16.11) last year

2025-11-12T21:26:43.000Z - 7 months ago

Aethlon Medical reports Q2 EPS ($3.74) vs. ($16.11) last year

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Nov 12, 2025, 4:15 PM EST - 7 months ago

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Nov 7, 2025, 8:01 AM EST - 7 months ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Aethlon Medical trading halted, news pending

2025-10-17T23:50:14.000Z - 8 months ago

Aethlon Medical trading halted, news pending

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Oct 7, 2025, 8:01 AM EDT - 8 months ago

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Aethlon Medical announces pricing of $4.5M common stock, warrant offering

2025-09-04T13:25:35.000Z - 10 months ago

Aethlon Medical announces pricing of $4.5M common stock, warrant offering

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Sep 4, 2025, 9:15 AM EDT - 10 months ago

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

Aethlon Medical announces issuance of patents protecting Hemopurifier

2025-09-03T12:11:26.000Z - 10 months ago

Aethlon Medical announces issuance of patents protecting Hemopurifier

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Sep 3, 2025, 8:01 AM EDT - 10 months ago

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

Aethlon Medical Registration statement: Registration Filing

Aug 29, 2025, 8:00 AM EDT - 10 months ago

Aethlon Medical Registration statement: Registration Filing

Why Is Aethlon Medical Stock (AEMD) Up 60% Today?

2025-08-21T23:54:00.000Z - 10 months ago

Why Is Aethlon Medical Stock (AEMD) Up 60% Today?

Aethlon Medical files to sell common stock, warrants, no amount given

2025-08-20T21:25:09.000Z - 10 months ago

Aethlon Medical files to sell common stock, warrants, no amount given

Aethlon Medical Registration statement: Registration Filing

Aug 20, 2025, 8:00 AM EDT - 10 months ago

Aethlon Medical Registration statement: Registration Filing

Aethlon Medical Earnings Call Transcript: Q1 2026

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Aethlon Medical Earnings Call Transcript: Q1 2026

Aethlon Medical Quarterly report: Q1 2026

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Aethlon Medical Quarterly report: Q1 2026

Aethlon Medical Earnings release: Q1 2026

Aug 13, 2025, 4:30 PM EDT - 10 months ago

Aethlon Medical Earnings release: Q1 2026

Aethlon Medical reports Q1 EPS (85c) vs. ($2.76) last year

2025-08-13T20:20:55.000Z - 10 months ago

Aethlon Medical reports Q1 EPS (85c) vs. ($2.76) last year

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aug 13, 2025, 4:15 PM EDT - 10 months ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Aug 5, 2025, 8:01 AM EDT - 11 months ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Jul 15, 2025, 8:01 AM EDT - 11 months ago

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

Aethlon Medical assumed with a Neutral at H.C. Wainwright

2025-07-07T10:10:42.000Z - 1 year ago

Aethlon Medical assumed with a Neutral at H.C. Wainwright

Aethlon Medical reports FY25 EPS ($8.58) vs. ($38.87) last year

2025-06-27T12:35:09.000Z - 1 year ago

Aethlon Medical reports FY25 EPS ($8.58) vs. ($38.87) last year

Aethlon Medical Earnings Call Transcript: Q4 2025

Jun 26, 2025, 4:30 PM EDT - 1 year ago

Aethlon Medical Earnings Call Transcript: Q4 2025

Aethlon Medical Annual report: Q4 2025

Jun 26, 2025, 4:30 PM EDT - 1 year ago

Aethlon Medical Annual report: Q4 2025

Aethlon Medical Earnings release: Q4 2025

Jun 26, 2025, 4:30 PM EDT - 1 year ago

Aethlon Medical Earnings release: Q4 2025

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Jun 26, 2025, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Jun 20, 2025, 8:01 AM EDT - 1 year ago

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Jun 18, 2025, 8:01 AM EDT - 1 year ago

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical Transcript: Emerging Growth Conference 83

Jun 17, 2025, 3:40 PM EDT - 1 year ago

Aethlon Medical Transcript: Emerging Growth Conference 83

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

Jun 9, 2025, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

May 14, 2025, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Aethlon Medical Proxy statement: Proxy Filing

Apr 18, 2025, 8:00 AM EDT - 1 year ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical Transcript: Emerging Growth Virtual Conference

Mar 26, 2025, 3:25 PM EDT - 1 year ago

Aethlon Medical Transcript: Emerging Growth Virtual Conference

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Mar 10, 2025, 8:01 AM EDT - 1 year ago

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Aethlon Medical Transcript: Emerging Growth Conference 79

Feb 19, 2025, 11:25 AM EST - 1 year ago

Aethlon Medical Transcript: Emerging Growth Conference 79

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 13, 2025, 8:01 AM EST - 1 year ago

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Aethlon Medical Earnings Call Transcript: Q3 2025

Feb 12, 2025, 4:30 PM EST - 1 year ago

Aethlon Medical Earnings Call Transcript: Q3 2025

Aethlon Medical Quarterly report: Q3 2025

Feb 12, 2025, 4:30 PM EST - 1 year ago

Aethlon Medical Quarterly report: Q3 2025

Aethlon Medical Earnings release: Q3 2025

Feb 12, 2025, 4:30 PM EST - 1 year ago

Aethlon Medical Earnings release: Q3 2025

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 12, 2025, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Feb 5, 2025, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Jan 29, 2025, 8:01 AM EST - 1 year ago

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Dec 20, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Nov 14, 2024, 8:00 AM EST - 1 year ago

Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally

Aethlon Medical Earnings Call Transcript: Q2 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aethlon Medical Earnings Call Transcript: Q2 2025

Aethlon Medical Quarterly report: Q2 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aethlon Medical Quarterly report: Q2 2025

Aethlon Medical Earnings release: Q2 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aethlon Medical Earnings release: Q2 2025

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 13, 2024, 4:15 PM EST - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Innovative Medical Technology Advances with First Patient Enrollments

Nov 12, 2024, 8:00 AM EST - 1 year ago

Innovative Medical Technology Advances with First Patient Enrollments

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 11, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Nov 6, 2024, 8:01 AM EST - 1 year ago

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

Aethlon Medical Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 15, 2024, 4:30 PM EDT - 1 year ago

Aethlon Medical Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 8, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Sep 19, 2024, 8:01 AM EDT - 1 year ago

Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India

Aethlon Medical to Present at Virtual Investor Conferences in September

Sep 17, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical to Present at Virtual Investor Conferences in September

Innovation Driving Cancer's Solid Tumors Market

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Innovation Driving Cancer's Solid Tumors Market

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Sep 16, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Sep 13, 2024, 8:35 AM EDT - 1 year ago

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aug 27, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys

Aethlon Medical Proxy statement: Proxy Filing

Aug 15, 2024, 8:00 AM EDT - 1 year ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical Proxy statement: Proxy Filing

Aug 15, 2024, 8:00 AM EDT - 1 year ago

Aethlon Medical Proxy statement: Proxy Filing

Aethlon Medical Earnings Call Transcript: Q1 2025

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Aethlon Medical Earnings Call Transcript: Q1 2025

Aethlon Medical Quarterly report: Q1 2025

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Aethlon Medical Quarterly report: Q1 2025

Aethlon Medical Earnings release: Q1 2025

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Aethlon Medical Earnings release: Q1 2025

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

Aug 14, 2024, 4:15 PM EDT - 1 year ago

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aug 12, 2024, 9:01 AM EDT - 1 year ago

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aug 12, 2024, 8:01 AM EDT - 1 year ago

Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aug 6, 2024, 9:12 AM EDT - 2 years ago

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024

Aethlon Medical Earnings Call Transcript: Q4 2024

Jun 27, 2024, 4:30 PM EDT - 2 years ago

Aethlon Medical Earnings Call Transcript: Q4 2024

Aethlon Medical Annual report: Q4 2024

Jun 27, 2024, 4:30 PM EDT - 2 years ago

Aethlon Medical Annual report: Q4 2024

Aethlon Medical Earnings release: Q4 2024

Jun 27, 2024, 4:30 PM EDT - 2 years ago

Aethlon Medical Earnings release: Q4 2024

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Jun 27, 2024, 4:15 PM EDT - 2 years ago

Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Jun 21, 2024, 8:01 AM EDT - 2 years ago

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024

Alpha__Trading
Alpha__Trading Jun. 11 at 7:40 PM
$AEMD not many shares left to buy, PR soon
0 · Reply
ZacksSCR
ZacksSCR Jun. 11 at 7:19 PM
$AEMD Clinical Study Advances to Final Cohort; Preclinical Activities Expand https://buff.ly/20Br26y
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:40 PM
$84B+ biotech M&A in Q1 2026. big pharma buying pipelines at scale. DPX platform sitting at the intersection of oncology and infectious disease with peer reviewed data. halt lifts when filing drops. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:35 PM
DPX covering oncology AND infectious disease simultaneously. two Nature publications. DoD melanoma funding application. CEPI Ebola submission. one platform, multiple disease categories. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
ProfitWhisperer
ProfitWhisperer Jun. 11 at 4:31 PM
CEPI pre-proposal due tomorrow June 12. filing still pending. two catalysts that could completely change the story. $BVAXF $MRK $AEMD $EBS $REGN
0 · Reply
UNCLE_SCROOGE_
UNCLE_SCROOGE_ Jun. 11 at 3:23 PM
$AEMD flush the scam...🤣🤣🤣
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 2:52 PM
$CODX $CMND $AEMD
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 11:03 AM
$CODX $AEMD $VRAX
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 10:53 AM
$VRAX $EBS $CODX $AEMD $GOVX https://share.google/pX9BFFpjPEjwnE4FM
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 3:01 AM
$AEMD $VRAX $CODX $EBS $PGEN https://share.google/cpZbwOapzh3mC7jtI
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 2:46 AM
$AEMD $VSME $INHD $IXHL $PGEN
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 11 at 2:27 AM
$AEMD 🦠 AEMD 💉 has got this ☝️ https://share.google/m8Z7ezpZl2jRVIM57
0 · Reply
CoffeeRocks
CoffeeRocks Jun. 10 at 10:52 PM
$AEMD Bullish elements: Strong emphasis on clinical progress with the Hemopurifier device. Australian oncology trial advanced (Cohort 2 completed safely; Cohort 3 started, first patient treated). Preclinical work in rheumatoid arthritis, chronic kidney disease, and simplified blood pump compatibility. IP expansions (patents into 2040s) and monitoring Ebola potential. Management highlighted platform potential and cost efficiency. 
1 · Reply
CoffeeRocks
CoffeeRocks Jun. 10 at 10:19 PM
$AEMD $AIM $CODX AEMD cheapies available 🥳🔜 3$
0 · Reply
KL2222
KL2222 Jun. 10 at 10:01 PM
$AEMD Making up for the small amount im down with BATL and SKYQ
0 · Reply
ActiveTendyDeployment
ActiveTendyDeployment Jun. 10 at 9:58 PM
$AEMD goodnight sweet prince
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jun. 10 at 9:57 PM
$AEMD Q4 '26 Earnings Results & Recap Reported GAAP EPS of $0.40 up 101.07% YoY
0 · Reply
AveraveJoeTrader
AveraveJoeTrader Jun. 10 at 9:29 PM
$AEMD Why the selloff? Just got home
1 · Reply
Alpha__Trading
Alpha__Trading Jun. 10 at 9:16 PM
$AEMD could use a grilled cheese sandwich right about now
1 · Reply
KL2222
KL2222 Jun. 10 at 9:10 PM
$AEMD that was a hard selloff...
0 · Reply
PharmGal
PharmGal Jun. 10 at 9:07 PM
$AEMD In the 2014 Ebola outbreak, the hemopurifier saved an unconscious physician with multiple failing organs. Full recovery. It's a cartridge filter that gets added to a dialysis-like machine. https://www.prnewswire.com/news-releases/aethlon-medicals-hemopurifier-used-in-successful-treatment-of-patient-with-advanced-ebola-infection-282713131.html
0 · Reply
stockwitsuser2449
stockwitsuser2449 Jun. 10 at 9:00 PM
$AEMD any buyters for 2?
0 · Reply